Newcells Biotech is collaborating with industry leaders and expert academics in a European-wide interdisciplinary initiative to develop animal-free methods for drug safety evaluations. The initiative (the EU funded in3 project) is driven
Retinitis pigmentosa (RP) is a group of degenerative disorders of the retina, caused by mutations in one of more than 60 genes, including the genes for making rhodopsin, pre-mRNA processing factors and usherin. The genes
Retinal organoids are becoming a powerful tool in the process of drug discovery, as recently shown by researchers at Newcells Biotech and Newcastle University in a study led by Professor Majlinda Lako
Dr Colin Brown will be presenting two posters at 22nd North American Meeting of the International Society for the Study of Xenobiotics.
Age-related macular degeneration (AMD) remains the commonest cause of blindness in the developed world. This review article by Dr Valeria Chichagova and Dr Dean Hallam provides an overview of progress made, ongoing studies and challenges ahead.
Dr Valeria Chichagova will be presenting at the inaugural Faculty of Medical Science (FMS) Post-Doc Symposium on Friday 15th June 2018.